Cheuk‐Ting Law

3.5k total citations · 2 hit papers
20 papers, 2.4k citations indexed

About

Cheuk‐Ting Law is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Cheuk‐Ting Law has authored 20 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 12 papers in Cancer Research and 3 papers in Immunology. Recurrent topics in Cheuk‐Ting Law's work include RNA modifications and cancer (10 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). Cheuk‐Ting Law is often cited by papers focused on RNA modifications and cancer (10 papers), Cancer, Hypoxia, and Metabolism (5 papers) and Epigenetics and DNA Methylation (5 papers). Cheuk‐Ting Law collaborates with scholars based in Hong Kong, China and Switzerland. Cheuk‐Ting Law's co-authors include Chun‐Ming Wong, Carmen Chak‐Lui Wong, Irene Oi‐Lin Ng, Felice Ho‐Ching Tsang, Lai Wei, David Kung‐Chun Chiu, Joyce Man‐Fong Lee, Jialing Shen, Daniel Wai‐Hung Ho and Mengnuo Chen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Cheuk‐Ting Law

20 papers receiving 2.4k citations

Hit Papers

RNA N6‐methyladenosine methyltransferase‐like 3 promotes ... 2017 2026 2020 2023 2017 2019 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2
    2017 1.0k citations Mengnuo Chen, Lai Wei et al. Hepatology profile →
  2. Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC
    2019 297 citations Lai Wei, Derek Lee et al. Nature Communications profile →

Peers

Cheuk‐Ting Law
Felice Ho‐Ching Tsang Hong Kong
Mu Xu China
Joyce Man‐Fong Lee Hong Kong
Zhaoqing Tang China
Zhibin Liao China
Joseph A. Bokar United States
Tony Gutschner Germany
Liangliang Ren China
Felice Ho‐Ching Tsang Hong Kong
Cheuk‐Ting Law
Citations per year, relative to Cheuk‐Ting Law Cheuk‐Ting Law (= 1×) peers Felice Ho‐Ching Tsang

Countries citing papers authored by Cheuk‐Ting Law

Since Specialization
Citations

This map shows the geographic impact of Cheuk‐Ting Law's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheuk‐Ting Law with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheuk‐Ting Law more than expected).

Fields of papers citing papers by Cheuk‐Ting Law

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cheuk‐Ting Law. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheuk‐Ting Law. The network helps show where Cheuk‐Ting Law may publish in the future.

Co-authorship network of co-authors of Cheuk‐Ting Law

This figure shows the co-authorship network connecting the top 25 collaborators of Cheuk‐Ting Law. A scholar is included among the top collaborators of Cheuk‐Ting Law based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cheuk‐Ting Law. Cheuk‐Ting Law is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yuen, Vincent Wai‐Hin, Jialing Shen, Don Wai‐Ching Chin, et al.. (2023). Inhibition of CAF-1 histone chaperone complex triggers cytosolic DNA and dsRNA sensing pathways and induces intrinsic immunity of hepatocellular carcinoma. Hepatology. 80(2). 295–311. 4 indexed citations
2.
Chan, Cerise Yuen‐Ki, David Kung‐Chun Chiu, Vincent Wai‐Hin Yuen, et al.. (2022). CFI-402257, a TTK inhibitor, effectively suppresses hepatocellular carcinoma. Proceedings of the National Academy of Sciences. 119(32). e2119514119–e2119514119. 38 indexed citations
3.
Wei, Lai, Gengchao Wang, Cheuk‐Ting Law, et al.. (2022). In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 14(5). 1053–1076. 12 indexed citations
4.
Yuen, Vincent Wai‐Hin, David Kung‐Chun Chiu, Cheuk‐Ting Law, et al.. (2022). Using mouse liver cancer models based on somatic genome editing to predict immune checkpoint inhibitor responses. Journal of Hepatology. 78(2). 376–389. 42 indexed citations
5.
Shen, Jialing, Chunxue Yang, Misty Shuo Zhang, et al.. (2022). Histone chaperone FACT complex coordinates with HIF to mediate an expeditious transcription program to adapt to poorly oxygenated cancers. Cell Reports. 38(5). 110304–110304. 11 indexed citations
6.
Bao, Macus Hao‐Ran, Chunxue Yang, Aki Pui‐Wah Tse, et al.. (2021). Genome-wide CRISPR-Cas9 knockout library screening identified PTPMT1 in cardiolipin synthesis is crucial to survival in hypoxia in liver cancer. Cell Reports. 34(4). 108676–108676. 44 indexed citations
7.
Wei, Lai, Mengnuo Chen, Don Wai‐Ching Chin, et al.. (2021). Bromodomain-containing protein BRPF1 is a therapeutic target for liver cancer. Communications Biology. 4(1). 888–888. 30 indexed citations
8.
Lee, Derek, Misty Shuo Zhang, Felice Ho‐Ching Tsang, et al.. (2021). Adaptive and Constitutive Activations of Malic Enzymes Confer Liver Cancer Multilayered Protection Against Reactive Oxygen Species. Hepatology. 74(2). 776–796. 19 indexed citations
9.
Berrens, Rebecca V., Andrian Yang, Christopher Laumer, et al.. (2021). Locus-specific expression of transposable elements in single cells with CELLO-seq. Nature Biotechnology. 40(4). 546–554. 50 indexed citations
10.
Shen, Jialing, Mengnuo Chen, Derek Lee, et al.. (2019). Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression. Gut. 69(2). 329–342. 42 indexed citations
11.
Chiu, David Kung‐Chun, Aki Pui‐Wah Tse, Cheuk‐Ting Law, et al.. (2019). Hypoxia regulates the mitochondrial activity of hepatocellular carcinoma cells through HIF/HEY1/PINK1 pathway. Cell Death and Disease. 10(12). 934–934. 136 indexed citations
12.
Wei, Lai, Derek Lee, Cheuk‐Ting Law, et al.. (2019). Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nature Communications. 10(1). 4681–4681. 297 indexed citations breakdown →
13.
Tsang, Felice Ho‐Ching, Cheuk‐Ting Law, Don Wai‐Ching Chin, et al.. (2019). Aberrant Super‐Enhancer Landscape in Human Hepatocellular Carcinoma. Hepatology. 69(6). 2502–2517. 107 indexed citations
14.
Law, Cheuk‐Ting, Lai Wei, Felice Ho‐Ching Tsang, et al.. (2018). HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma. Hepatology. 69(5). 2013–2030. 59 indexed citations
15.
Wei, Lai, David Kung‐Chun Chiu, Felice Ho‐Ching Tsang, et al.. (2017). Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. Journal of Hepatology. 67(4). 758–769. 123 indexed citations
16.
Lee, Derek, Mingjing Xu, David Kung‐Chun Chiu, et al.. (2017). Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. Journal of Clinical Investigation. 127(5). 1856–1872. 110 indexed citations
17.
Chen, Mengnuo, Lai Wei, Cheuk‐Ting Law, et al.. (2017). RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2. Hepatology. 67(6). 2254–2270. 1032 indexed citations breakdown →
18.
Lai, Robin Kit‐Ho, Mingjing Xu, David Kung‐Chun Chiu, et al.. (2016). NDUFA4L2 Fine-tunes Oxidative Stress in Hepatocellular Carcinoma. Clinical Cancer Research. 22(12). 3105–3117. 69 indexed citations
19.
Wong, Chun‐Ming, Lai Wei, Cheuk‐Ting Law, et al.. (2015). Up‐regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis. Hepatology. 63(2). 474–487. 138 indexed citations
20.
Wong, Chun‐Ming, Lai Wei, Sandy Leung–Kuen Au, et al.. (2015). MiR-200b/200c/429 subfamily negatively regulates Rho/ROCK signaling pathway to suppress hepatocellular carcinoma metastasis. Oncotarget. 6(15). 13658–13670. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Felice Ho‐Ching Tsang Breakdown of academic impact, for papers by Mu Xu Breakdown of academic impact, for papers by Joyce Man‐Fong Lee Breakdown of academic impact, for papers by Zhaoqing Tang Breakdown of academic impact, for papers by Zhibin Liao Breakdown of academic impact, for papers by Joseph A. Bokar Breakdown of academic impact, for papers by Tony Gutschner Breakdown of academic impact, for papers by Liangliang Ren
Rankless by CCL
2026